Brain Tumor Segmentation (BraTS) Challenge 2024: Meningioma Radiotherapy Planning Automated Segmentation

no code implementations • 28 May 2024 • Dominic LaBella, Katherine Schumacher, Michael Mix, Kevin Leu, Shan McBurney-Lin, Pierre Nedelec, Javier Villanueva-Meyer, Jonathan Shapey, Tom Vercauteren, Kazumi Chia, Omar Al-Salihi, Justin Leu, Lia Halasz, Yury Velichko, Chunhao Wang, John Kirkpatrick, Scott Floyd, Zachary J. Reitman, Trey Mullikin, Ulas Bagci, Sean Sachdev, Jona A. Hattangadi-Gluth, Tyler Seibert, Nikdokht Farid, Connor Puett, Matthew W. Pease, Kevin Shiue, Syed Muhammad Anwar, Shahriar Faghani, Muhammad Ammar Haider, Pranav Warman, Jake Albrecht, András Jakab, Mana Moassefi, Verena Chung, Alejandro Aristizabal, Alexandros Karargyris, Hasan Kassem, Sarthak Pati, Micah Sheller, Christina Huang, Aaron Coley, Siddharth Ghanta, Alex Schneider, Conrad Sharp, Rachit Saluja, Florian Kofler, Philipp Lohmann, Phillipp Vollmuth, Louis Gagnon, Maruf Adewole, Hongwei Bran Li, Anahita Fathi Kazerooni, Nourel Hoda Tahon, Udunna Anazodo, Ahmed W. Moawad, Bjoern Menze, Marius George Linguraru, Mariam Aboian, Benedikt Wiestler, Ujjwal Baid, Gian-Marco Conte, Andreas M. T. Rauschecker, Ayman Nada, Aly H. Abayazeed, Raymond Huang, Maria Correia de Verdier, Jeffrey D. Rudie, Spyridon Bakas, Evan Calabrese

The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT) challenge aims to advance automated segmentation algorithms using the largest known multi-institutional dataset of radiotherapy planning brain MRIs with expert-annotated target labels for patients with intact or post-operative meningioma that underwent either conventional external beam radiotherapy or stereotactic radiosurgery.

BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions

no code implementations • 17 May 2024 • Spyridon Bakas, Siddhesh P. Thakur, Shahriar Faghani, Mana Moassefi, Ujjwal Baid, Verena Chung, Sarthak Pati, Shubham Innani, Bhakti Baheti, Jake Albrecht, Alexandros Karargyris, Hasan Kassem, MacLean P. Nasrallah, Jared T. Ahrendsen, Valeria Barresi, Maria A. Gubbiotti, Giselle Y. López, Calixto-Hope G. Lucas, Michael L. Miller, Lee A. D. Cooper, Jason T. Huse, William R. Bell

Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise.

Benchmarking

Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge

no code implementations • 16 May 2024 • Dominic LaBella, Ujjwal Baid, Omaditya Khanna, Shan McBurney-Lin, Ryan McLean, Pierre Nedelec, Arif Rashid, Nourel Hoda Tahon, Talissa Altes, Radhika Bhalerao, Yaseen Dhemesh, Devon Godfrey, Fathi Hilal, Scott Floyd, Anastasia Janas, Anahita Fathi Kazerooni, John Kirkpatrick, Collin Kent, Florian Kofler, Kevin Leu, Nazanin Maleki, Bjoern Menze, Maxence Pajot, Zachary J. Reitman, Jeffrey D. Rudie, Rachit Saluja, Yury Velichko, Chunhao Wang, Pranav Warman, Maruf Adewole, Jake Albrecht, Udunna Anazodo, Syed Muhammad Anwar, Timothy Bergquist, Sully Francis Chen, Verena Chung, Gian-Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov, Nastaran Khalili, Juan Eugenio Iglesias, Zhifan Jiang, Elaine Johanson, Koen van Leemput, Hongwei Bran Li, Marius George Linguraru, Xinyang Liu, Aria Mahtabfar, Zeke Meier, Ahmed W. Moawad, John Mongan, Marie Piraud, Russell Takeshi Shinohara, Walter F. Wiggins, Aly H. Abayazeed, Rachel Akinola, András Jakab, Michel Bilello, Maria Correia de Verdier, Priscila Crivellaro, Christos Davatzikos, Keyvan Farahani, John Freymann, Christopher Hess, Raymond Huang, Philipp Lohmann, Mana Moassefi, Matthew W. Pease, Phillipp Vollmuth, Nico Sollmann, David Diffley, Khanak K. Nandolia, Daniel I. Warren, Ali Hussain, Pascal Fehringer, Yulia Bronstein, Lisa Deptula, Evan G. Stein, Mahsa Taherzadeh, Eduardo Portela de Oliveira, Aoife Haughey, Marinos Kontzialis, Luca Saba, Benjamin Turner, Melanie M. T. Brüßeler, Shehbaz Ansari, Athanasios Gkampenis, David Maximilian Weiss, Aya Mansour, Islam H. Shawali, Nikolay Yordanov, Joel M. Stein, Roula Hourani, Mohammed Yahya Moshebah, Ahmed Magdy Abouelatta, Tanvir Rizvi, Klara Willms, Dann C. Martin, Abdullah Okar, Gennaro D'Anna, Ahmed Taha, Yasaman Sharifi, Shahriar Faghani, Dominic Kite, Marco Pinho, Muhammad Ammar Haider, Alejandro Aristizabal, Alexandros Karargyris, Hasan Kassem, Sarthak Pati, Micah Sheller, Michelle Alonso-Basanta, Javier Villanueva-Meyer, Andreas M. Rauschecker, Ayman Nada, Mariam Aboian, Adam E. Flanders, Benedikt Wiestler, Spyridon Bakas, Evan Calabrese

The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0. 976, 0. 976, and 0. 964 for enhancing tumor, tumor core, and whole tumor, respectively and a corresponding average DSC of 0. 899, 0. 904, and 0. 871, respectively.

Face Anonymization Segmentation

RIDGE: Reproducibility, Integrity, Dependability, Generalizability, and Efficiency Assessment of Medical Image Segmentation Models

no code implementations • 16 Jan 2024 • Farhad Maleki, Linda Moy, Reza Forghani, Tapotosh Ghosh, Katie Ovens, Steve Langer, Pouria Rouzrokh, Bardia Khosravi, Ali Ganjizadeh, Daniel Warren, Roxana Daneshjou, Mana Moassefi, Atlas Haddadi Avval, Susan Sotardi, Neil Tenenholtz, Felipe Kitamura, Timothy Kline

Deep learning techniques, despite their potential, often suffer from a lack of reproducibility and generalizability, impeding their clinical adoption.

Image Segmentation Medical Image Segmentation +2

Multitask Brain Tumor Inpainting with Diffusion Models: A Methodological Report

1 code implementation • 21 Oct 2022 • Pouria Rouzrokh, Bardia Khosravi, Shahriar Faghani, Mana Moassefi, Sanaz Vahdati, Bradley J. Erickson

Although the majority of inpainting techniques for medical imaging data use generative adversarial networks (GANs), the performance of these algorithms is frequently suboptimal due to their limited output variety, a problem that is already well-known for GANs.

Denoising